AVALO THERAPEUTICS, INC. Cash and Cash Equivalents
AVALO THERAPEUTICS, INC. (AVTX) had Cash and Cash Equivalents of $85.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $85.38M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $24.99M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $15.86M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $26.96M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $85.38M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $24.99M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $15.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $26.96M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $42.29M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $125.05M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $134.55M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $81.86M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $93.43M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $110.18M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $7.42M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $10.18M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $6.31M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $16.69M 10-Q/A · filed 2024-07-11 | |
| 2022-12-31 | $13.17M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $16.94M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $11.25M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $38.47M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $54.59M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $71.51M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $40.44M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $38.29M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $18.92M 10-K · filed 2022-03-02 | $18.92M 10-K · filed 2021-03-08 |
| 2020-09-30 | $33.39M 10-Q · filed 2021-11-09 | $33.39M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $45.39M 10-Q · filed 2021-08-02 | $45.39M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.66M 10-Q · filed 2021-05-13 | $5.66M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.61M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $5.25M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $9.39M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $16.12M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $10.65M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $6.84M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $2.18M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $2.52M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $2.47M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $23.96M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $5.46M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $3.00M 10-Q · filed 2018-05-11 | |
| 2016-12-31 | $5.13M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $8.82M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $11.88M 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $16.60M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $21.16M 10-K · filed 2018-04-02 | |
| 2015-09-30 | $3.31M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $6.14M 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $8.66M 10-Q · filed 2016-05-16 | |
| 2014-12-31 | $11.74M 10-K · filed 2018-04-02 | |
| 2014-09-30 | $15.73M 10-Q · filed 2015-11-13 | |
| 2013-12-31 | $3.42M 10-K · filed 2017-03-14 | |
| 2012-12-31 | $9.52M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |